Menthacarin for the Treatment of Epigastric Pain Syndrome (EPS) and Postprandial Distress Syndrome (PDS): Data of a placebo-controlled trial revisited
G Holtmann, G Rich, V Wieland, P Funk, M Kieser, S Koehler · Zeitschrift für Gastroenterologie · 2015 · Heft 08
Bibliografische Angaben
Zusammenfassung
Introduction: The Rome III criteria have been proposed to categorise patients with FD into epigastric pain syndrome (EPS) and postprandial distress syndrome (PDS). This categorisation is intended to better target therapy. However, very little is known if specific symptom-types respond better to specific treatments. We thus analysed the data from a prospective, double-blind, multicentre clinical trial with Menthacarin* (a proprietary combination of essential oils of a specified quality from Mentha x piperita L. (90 mg WS® 1340) and Carum carvi (50 mg WS® 1520)) with regard to the efficacy of Menthacarin in EPS an…